Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
Waters Corporation announced the global commercial launch of the BD FACSDiscover A7 Cell Analyzer, extending its FACSDiscover flow cytometry platform with a standardized spectral cytometry instrument aimed at academic, pharmaceutical, and CRO labs. The analyzer enables routine 50+ parameter experiments via BD SpectralFX Technology and uses FACSTruQ automated calibration to keep variability below a 10% coefficient of variation across more than 50 dyes, with guided workflows and an integrated autoloader. The launch lands during the transition period after Waters acquired BD's Biosciences and Diagnostic Solutions businesses, with BD still the legal manufacturer pending regulatory transfers.
Key figures
- Dye palette
- 50+
- Waters employees
- ~15,000
- Parameters per cell
- 50+
- Spectralfx lasers up to
- 5
- Coefficient of variation
- <10%
- Spectralfx fluorescence detectors
- 78
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.